8-K Announcements
6Apr 28, 2026·SEC
Feb 4, 2026·SEC
Jan 7, 2026·SEC
Omega Healthcare Investors, Inc. (OHI) fundamental analysis — strengths, weaknesses & financial health based on data analysis
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
Omega Healthcare Investors, Inc. (OHI) stock price & volume — 10-year historical chart
Omega Healthcare Investors, Inc. (OHI) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Omega Healthcare Investors, Inc. (OHI) EPS & revenue vs analyst estimates — last 4 quarters
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | Apr 28, 2026 | $0.47vs $0.49-4.2% | $267Mvs $264M+1.1% |
| Q1 2026 | Feb 4, 2026 | $0.55vs $0.50+11.1% | $261Mvs $265M-1.2% |
| Q4 2025 | Oct 30, 2025 | $0.79vs $0.77+2.6% | $312Mvs $287M+8.5% |
| Q3 2025 | Jul 31, 2025 | $0.77vs $0.75+2.7% | $283Mvs $248M+14.0% |
Omega Healthcare Investors, Inc. (OHI) competitors in Senior housing and skilled nursing — business model, growth, and fundamentals comparison
Omega Healthcare Investors, Inc. (OHI) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
Omega Healthcare Investors, Inc. (OHI) annual income statement — 10-year revenue, gross profit & net income history
| Line item | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 908.38M | 881.68M | 928.83M | 892.38M | 1.06B | 878.24M | 949.74M | 1.05B | 1.2B | 1.24B |
| Revenue Growth % | 0.84% | -2.94% | 5.35% | -3.92% | 19.1% | -17.37% | 8.14% | 10.7% | 13.95% | 14.19% |
| Property Operating Expenses | 0 | 0 | 14.93M | 12.32M | 12.26M | 15.5M | 15.03M | 14.56M | 664.93M | 180.21M |
| Net Operating Income (NOI) | 908.38M▲ 0% | 881.68M▼ 2.9% | 913.9M▲ 3.7% | 880.07M▼ 3.7% | 1.05B▲ 19.4% | 862.74M▼ 17.9% | 934.72M▲ 8.3% | 1.04B▲ 10.9% | 533.17M▼ 48.6% | 1.06B▲ 0% |
| NOI Margin % | 100% | 100% | 98.39% | 98.62% | 98.85% | 98.24% | 98.42% | 98.62% | 44.5% | 85.45% |
| Operating Expenses | 593.21M | 384.09M | 362.15M | 427.81M | 484.38M | 470.47M | 445.74M | 377.17M | -216.27M | 175.22M |
| G&A Expenses | 47.68M | 63.51M | 57.87M | 59.89M | 64.63M | 69.4M | 81.5M | 88M | 0 | 62.61M |
| EBITDA | 602.76M | 778.87M | 853.43M | 782.18M | 908.19M | 724.68M | 808.65M | 964.31M | 1.07B | 1.13B |
| EBITDA Margin % | 66.36% | 88.34% | 91.88% | 87.65% | 85.45% | 82.52% | 85.14% | 91.72% | 89.7% | 90.85% |
| Depreciation & Amortization | 287.59M | 281.28M | 301.68M | 329.92M | 342.01M | 332.41M | 319.68M | 304.65M | 325.25M | 329.51M |
| D&A / Revenue % | 31.66% | 31.9% | 32.48% | 36.97% | 32.18% | 37.85% | 33.66% | 28.98% | 27.15% | 26.6% |
| Operating Income | 315.17M▲ 0% | 497.59M▲ 57.9% | 551.75M▲ 10.9% | 452.25M▼ 18.0% | 566.17M▲ 25.2% | 392.28M▼ 30.7% | 488.97M▲ 24.6% | 659.66M▲ 34.9% | 749.44M▲ 13.6% | 796.06M▲ 0% |
| Operating Margin % | 34.7% | 56.44% | 59.4% | 50.68% | 53.27% | 44.67% | 51.48% | 62.74% | 62.55% | 64.26% |
| Interest Expense | 220.24M | 201.42M | 208.72M | 223.39M | 234.6M | 233.24M | 235.53M | 221.72M | 220.53M | 4M |
| Interest Coverage | 1.48x | 2.47x | 2.65x | 1.73x | 2.77x | 2.87x | 2.09x | 2.90x | 3.83x | - |
| Non-Operating Income | -10.99M | -345K | -814K | 66.54M | -84.51M | -277.11M | -2.19M | 17.2M | -95.31M | -92.88M |
| Pretax Income | 105.92M▲ 0% | 296.51M▲ 179.9% | 354.79M▲ 19.7% | 168.47M▼ 52.5% | 432.14M▲ 156.5% | 443.4M▲ 2.6% | 255.05M▼ 42.5% | 428.66M▲ 68.1% | 624.22M▲ 45.6% | 672.23M▲ 0% |
| Pretax Margin % | 11.66% | 33.63% | 38.2% | 18.88% | 40.66% | 50.49% | 26.85% | 40.77% | 52.1% | 54.26% |
| Income Tax | 3.25M | 3.01M | 2.84M | 4.92M | 3.84M | 4.56M | 6.25M | 10.86M | 14.75M | 16.24M |
| Effective Tax Rate % | 3.07% | 1.02% | 0.8% | 2.92% | 0.89% | 1.03% | 2.45% | 2.53% | 2.36% | 2.42% |
| Net Income | 100.42M▲ 0% | 281.58M▲ 180.4% | 341.12M▲ 21.1% | 159.33M▼ 53.3% | 416.74M▲ 161.6% | 426.93M▲ 2.4% | 242.18M▼ 43.3% | 406.33M▲ 67.8% | 590.11M▲ 45.2% | 632.09M▲ 0% |
| Net Margin % | 11.05% | 31.94% | 36.73% | 17.85% | 39.21% | 48.61% | 25.5% | 38.65% | 49.25% | 51.02% |
| Net Income Growth % | -72.59% | 180.4% | 21.15% | -53.29% | 161.56% | 2.44% | -43.27% | 67.78% | 45.23% | 41.09% |
| Funds From Operations (FFO) | 388.01M▲ 0% | 562.86M▲ 45.1% | 642.81M▲ 14.2% | 489.25M▼ 23.9% | 758.75M▲ 55.1% | 759.33M▲ 0.1% | 561.86M▼ 26.0% | 710.97M▲ 26.5% | 915.36M▲ 28.7% | 961.6M▲ 0% |
| FFO Margin % | 42.71% | 63.84% | 69.21% | 54.83% | 71.39% | 86.46% | 59.16% | 67.62% | 76.4% | 77.62% |
| FFO Growth % | -38.75% | 45.06% | 14.2% | -23.89% | 55.08% | 0.08% | -26.01% | 26.54% | 28.75% | 107.38% |
| FFO per Share | 1.88 | 2.68 | 2.89 | 2.08 | 3.11 | 3.11 | 2.24 | 2.63 | 2.95 | 3.05 |
| FFO Payout Ratio % | 129.53% | 93.93% | 87.76% | 125.15% | 84.04% | 83.35% | 114.6% | 96.41% | 85.25% | 61.48% |
| EPS (Diluted) | 0.51▲ 0% | 1.34▲ 162.7% | 1.54▲ 14.9% | 0.68▼ 55.8% | 1.75▲ 157.4% | 1.80▲ 2.9% | 1.00▼ 44.4% | 1.55▲ 55.0% | 1.94▲ 25.2% | 2.01▲ 0% |
| EPS Growth % | -73.16% | 162.75% | 14.93% | -55.84% | 157.35% | 2.86% | -44.44% | 55% | 25.16% | 28.57% |
| EPS (Basic) | 0.51 | 1.41 | 1.60 | 0.70 | 1.76 | 1.81 | 1.01 | 1.57 | 2.02 | - |
| Diluted Shares Outstanding | 206.79M | 209.71M | 222.13M | 235.1M | 244.34M | 244.29M | 250.45M | 270.45M | 310.7M | 315.13M |
Omega Healthcare Investors, Inc. (OHI) balance sheet — assets, liabilities & shareholders' equity
| Line item | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | 8.77B | 8.59B | 9.8B | 9.5B | 9.64B | 9.41B | 9.12B | 9.9B | 10.05B | 10.23B |
| Asset Growth % | -1.97% | -2.08% | 14.03% | -3.05% | 1.48% | -2.42% | -3.06% | 8.56% | 1.53% | 36.86% |
| Real Estate & Other Assets | 6.32B | 6.21B | 7.3B | 6.79B | 6.99B | 6.81B | 6.05B | 6.53B | 6.93B | -8.72B |
| PP&E (Net) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investment Securities | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K |
| Total Current Assets | 1.5B | 1.2B | 1.23B | 1.39B | 1.81B | 1.77B | 2.23B | 2.64B | 2.06B | 1.42B |
| Cash & Equivalents | 85.94M | 10.3M | 24.12M | 163.53M | 20.53M | 297.1M | 442.81M | 518.34M | 27.02M | 26.15M |
| Receivables | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K |
| Other Current Assets | 97.57M | 2.36M | 14.19M | 85.47M | 206.9M | 13M | 69.04M | 86.59M | 31.54M | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Liabilities | 4.89B | 4.83B | 5.46B | 5.46B | 5.53B | 5.6B | 5.36B | 5.17B | 4.61B | 4.78B |
| Total Debt | 4.57B | 4.54B | 5.14B | 5.17B | 5.25B | 5.29B | 5.07B | 4.84B | 4.26B | 4.44B |
| Net Debt | 4.49B | 4.53B | 5.11B | 5.01B | 5.23B | 4.99B | 4.62B | 4.32B | 4.23B | 4.42B |
| Long-Term Debt | 4.28B | 4.23B | 5.01B | 5.07B | 5.25B | 5.27B | 5.05B | 4.84B | 4.01B | 4.44B |
| Short-Term Borrowings | 290M | 313M | 125M | 101.16M | 0 | 19.25M | 20.4M | 0 | 242M | 0 |
| Capital Lease Obligations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Current Liabilities | 585.14M | 585.17M | 437.04M | 381.98M | 276.72M | 334.29M | 308.19M | 328.19M | 594.55M | 0 |
| Accounts Payable | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Liabilities | 0 | 0 | 0 | 0 | -8.2M | 0 | 0 | 0 | 0 | 338.24M |
| Total Equity | 3.89B▲ 0% | 3.76B▼ 3.2% | 4.34B▲ 15.2% | 4.04B▼ 6.9% | 4.11B▲ 1.8% | 3.8B▼ 7.4% | 3.76B▼ 1.1% | 4.73B▲ 25.7% | 5.44B▲ 15.0% | 5.46B▲ 0% |
| Equity Growth % | -7.69% | -3.18% | 15.2% | -6.92% | 1.77% | -7.42% | -1.08% | 25.74% | 15% | 77.81% |
| Shareholders Equity | 3.56B | 3.44B | 4.14B | 3.84B | 3.91B | 3.61B | 3.57B | 4.54B | 5.18B | 5.19B |
| Minority Interest | 333.17M | 320.04M | 201.17M | 194.73M | 201.39M | 193.91M | 187.71M | 194.17M | 259.2M | 263.54M |
| Common Stock | 19.83M | 20.23M | 22.66M | 23.12M | 23.91M | 23.43M | 24.53M | 27.91M | 29.55M | 29.78M |
| Additional Paid-in Capital | 4.94B | 5.07B | 5.99B | 6.15B | 6.43B | 6.31B | 6.67B | 7.92B | 8.69B | 8.78B |
| Retained Earnings | -1.37B | -1.61B | -1.84B | -2.32B | -2.54B | -2.75B | -3.15B | -3.43B | -3.62B | -3.67B |
| Preferred Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Return on Assets (ROA) | 1.13% | 3.24% | 3.71% | 1.65% | 4.36% | 4.48% | 2.61% | 4.27% | 5.92% | 6.1% |
| Return on Equity (ROE) | 2.48% | 7.36% | 8.42% | 3.81% | 10.23% | 10.79% | 6.4% | 9.57% | 11.6% | 11.85% |
| Debt / Assets | 52.11% | 52.85% | 52.43% | 54.43% | 54.51% | 56.21% | 55.58% | 48.89% | 42.35% | 43.4% |
| Debt / Equity | 1.18x | 1.21x | 1.18x | 1.28x | 1.28x | 1.39x | 1.35x | 1.02x | 0.78x | 0.78x |
| Net Debt / EBITDA | 7.44x | 5.82x | 5.99x | 6.40x | 5.76x | 6.89x | 5.72x | 4.48x | 3.94x | 3.94x |
| Book Value per Share | 18.80 | 17.95 | 19.52 | 17.17 | 16.81 | 15.57 | 15.02 | 17.49 | 17.51 | 17.31 |
Omega Healthcare Investors, Inc. (OHI) cash flow — operating, investing & free cash flow history
| Line item | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operations | 577.91M | 499.37M | 553.75M | 708.26M | 722.14M | 625.73M | 626.54M | 749.43M | 878.55M | 878.55M |
| Operating CF Growth % | -7.65% | -13.59% | 10.89% | 27.9% | 1.96% | -13.35% | 0.13% | 19.61% | 17.23% | 70.76% |
| Operating CF / Revenue % | 63.62% | 56.64% | 59.62% | 79.37% | 67.95% | 71.25% | 65.97% | 71.28% | 73.33% | 70.92% |
| Net Income | 104.91M | 293.88M | 351.95M | 163.54M | 428.3M | 438.84M | 241.72M | 417.8M | 609.47M | 632.09M |
| Depreciation & Amortization | 287.59M | 281.28M | 301.68M | 329.92M | 342.01M | 332.41M | 319.68M | 304.65M | 325.25M | 329.51M |
| Stock-Based Compensation | 15.21M | 15.99M | 15.36M | 18.82M | 21.41M | 27.3M | 0 | 36.7M | 44.19M | 38.97M |
| Other Non-Cash Items | 1.69M | -1.64M | 3.67M | -2.55M | 35.12M | -127.24M | 80.24M | -42.57M | -97.4M | 40.2M |
| Working Capital Changes | -89.43M | -127.88M | -124.06M | -30.84M | -94.03M | -45.58M | -15.1M | 32.85M | -2.95M | 15.56M |
| Cash from Investing | -285.13M | -173.22M | -378.95M | -89.06M | -524.17M | 442.85M | -9.78M | -671.16M | -539.79M | -829.07M |
| Acquisitions (Net) | 2.34M | 201.09M | -163.58M | -10.03M | -16.21M | -113K | -202K | -971K | -122.09M | -14.97M |
| Purchase of Investments | -139.05M | -385.71M | -100.31M | -167.94M | -164.79M | -619.22M | -739.92M | 0 | 0 | 0 |
| Sale of Investments | 95.7M | 181.37M | 91.28M | 149.87M | 111.11M | 759.05M | 750.22M | 8.43M | 4.24M | 38.73M |
| Other Investing | -157.43M | -30.54M | -66.67M | 14.15M | -359.21M | 350.36M | 18.14M | -678.62M | -421.94M | -852.83M |
| Cash from Financing | -303.81M | -410.7M | -153.96M | -485.55M | -341.12M | -789.45M | -473.31M | 26.32M | -838.26M | -436.24M |
| Dividends Paid | -502.6M | -528.7M | -564.13M | -612.31M | -637.65M | -632.89M | -643.87M | -685.45M | -780.39M | -789.59M |
| Common Dividends | -502.6M | -528.7M | -564.13M | -612.31M | -637.65M | -632.89M | -643.87M | -685.45M | -780.39M | -591.17M |
| Debt Issuance (Net) | 1000K | 1000K | -1000K | 1000K | 1000K | 1000K | -1000K | -1000K | -1000K | -1000K |
| Share Repurchases | -48K | -134K | 0 | 0 | 0 | -142.27M | 0 | 0 | 0 | -2.09M |
| Other Financing | -17.25M | 21.65M | -25.85M | -39.15M | -74.3M | -22.4M | 62.07M | -36.41M | -81.96M | 212.59M |
| Net Change in Cash | -10.47M▲ 0% | -85.14M▼ 713.3% | 21.71M▲ 125.5% | 134.18M▲ 518.1% | -143.15M▼ 206.7% | 276.23M▲ 293.0% | 144.09M▼ 47.8% | 104M▼ 27.8% | -494.17M▼ 575.1% | -350.75M▲ 0% |
| Exchange Rate Effect | 568K | -590K | 874K | 527K | 7K | -2.9M | 430K | -580K | 5.33M | 3.5M |
| Cash at Beginning | 107.28M | 96.81M | 11.67M | 33.38M | 167.56M | 24.41M | 300.64M | 444.73M | 548.74M | 54.56M |
| Cash at End | 96.81M | 11.67M | 33.38M | 167.56M | 24.41M | 300.64M | 444.73M | 548.74M | 54.56M | 53.32M |
| Free Cash Flow | 491.22M▲ 0% | 359.93M▼ 26.7% | 414.07M▲ 15.0% | 633.14M▲ 52.9% | 627.07M▼ 1.0% | 578.51M▼ 7.7% | 588.53M▲ 1.7% | 712.69M▲ 21.1% | 878.55M▲ 23.3% | 912.41M▲ 0% |
| FCF Growth % | -11.78% | -26.73% | 15.04% | 52.91% | -0.96% | -7.74% | 1.73% | 21.1% | 23.27% | 24.96% |
| FCF / Revenue % | 54.08% | 40.82% | 44.58% | 70.95% | 59% | 65.87% | 61.97% | 67.79% | 73.33% | 73.65% |
Omega Healthcare Investors, Inc. (OHI) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| FFO per Share | 1.88 | 2.68 | 2.89 | 2.08 | 3.11 | 3.11 | 2.24 | 2.63 | 2.95 | 3.05 |
| FFO Payout Ratio | 129.53% | 93.93% | 87.76% | 125.15% | 84.04% | 83.35% | 114.6% | 96.41% | 85.25% | 61.48% |
| NOI Margin | 100% | 100% | 98.39% | 98.62% | 98.85% | 98.24% | 98.42% | 98.62% | 44.5% | 85.45% |
| Net Debt / EBITDA | 7.44x | 5.82x | 5.99x | 6.40x | 5.76x | 6.89x | 5.72x | 4.48x | 3.94x | 3.94x |
| Debt / Assets | 52.11% | 52.85% | 52.43% | 54.43% | 54.51% | 56.21% | 55.58% | 48.89% | 42.35% | 43.4% |
| Interest Coverage | 1.48x | 2.47x | 2.65x | 1.73x | 2.77x | 2.87x | 2.09x | 2.90x | 3.83x | - |
| Book Value / Share | 18.8 | 17.95 | 19.52 | 17.17 | 16.81 | 15.57 | 15.02 | 17.49 | 17.51 | 17.31 |
| Revenue Growth | 0.84% | -2.94% | 5.35% | -3.92% | 19.1% | -17.37% | 8.14% | 10.7% | 13.95% | 14.19% |
Omega Healthcare Investors, Inc. (OHI) SEC filings — annual & quarterly reports (10-K, 10-Q)
Apr 28, 2026·SEC
Feb 4, 2026·SEC
Jan 7, 2026·SEC
Omega Healthcare Investors, Inc. (OHI) stock FAQ — growth, dividends, profitability & financials explained
Omega Healthcare Investors, Inc. (OHI) reported $1.24B in revenue for fiscal year 2025. This represents a 1594% increase from $73.1M in 1996.
Omega Healthcare Investors, Inc. (OHI) grew revenue by 14.0% over the past year. This is steady growth.
Yes, Omega Healthcare Investors, Inc. (OHI) is profitable, generating $632.1M in net income for fiscal year 2025 (49.3% net margin).
Yes, Omega Healthcare Investors, Inc. (OHI) pays a dividend with a yield of 5.45%. This makes it attractive for income-focused investors.
Omega Healthcare Investors, Inc. (OHI) has a return on equity (ROE) of 11.6%. This is reasonable for most industries.
Omega Healthcare Investors, Inc. (OHI) generated Funds From Operations (FFO) of $961.6M in the trailing twelve months. FFO is the primary profitability metric for REITs.
Omega Healthcare Investors, Inc. (OHI) offers a 5.45% dividend yield, which is attractive for income investors. REITs are required to distribute at least 90% of taxable income to shareholders.
Omega Healthcare Investors, Inc. (OHI) financial analysis — history, returns, DCA and operating performance tools
Analyst verdict, bull/bear case, risk factors and peer comparison
Historical returns with dividends reinvested
Dollar cost averaging vs lump sum
Yield, growth, payout safety & DRIP
EPS trends, net income & profitability
Long-term charts & historical price data
Sales growth patterns & revenue breakdown
30 years of market, efficiency and balance-sheet ratios
DCF intrinsic value, peer multiples & estimates